ProfileGDS4718 / 217032_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 55% 56% 51% 55% 53% 44% 44% 55% 57% 48% 48% 49% 45% 47% 47% 50% 45% 45% 43% 54% 50% 47% 55% 51% 45% 46% 50% 40% 57% 42% 43% 43% 56% 53% 41% 41% 44% 53% 49% 44% 52% 45% 42% 41% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.8081555
GSM549102patient 115, normal, homogenized [OPG study]5.8877356
GSM549104patient 119, normal, homogenized [OPG study]5.5509651
GSM549108patient 138, normal, homogenized [OPG study]5.8157355
GSM549119patient 077, normal, homogenized [OPG study]5.6711753
GSM549133patient 032, cancer, homogenized [OPG study]5.1035844
GSM549139patient 042, cancer, homogenized [OPG study]5.1795144
GSM549099patient 107, normal, homogenized [OPG study]5.7856355
GSM549109patient 139, normal, homogenized [OPG study]5.9755157
GSM549110patient 046, normal, homogenized [OPG study]5.3821948
GSM549114patient 063, normal, homogenized [OPG study]5.3553848
GSM549122patient 082, normal, homogenized [OPG study]5.4863349
GSM549134patient 033, cancer, homogenized [OPG study]5.2156445
GSM549136patient 036, cancer, homogenized [OPG study]5.2985447
GSM549140patient 044, cancer, homogenized [OPG study]5.3353747
GSM549111patient 047, normal, homogenized [OPG study]5.5080850
GSM549113patient 057, normal, homogenized [OPG study]5.1835245
GSM549132patient 031, cancer, homogenized [OPG study]5.25345
GSM549137patient 038, cancer, homogenized [OPG study]5.1282943
GSM549142patient 047, cancer, homogenized [OPG study]5.8896454
GSM549100patient 110, normal, homogenized [OPG study]5.5119450
GSM549107patient 135, normal, homogenized [OPG study]5.3376247
GSM549115patient 068, normal, homogenized [OPG study]5.7386155
GSM549116patient 072, normal, homogenized [OPG study]5.566451
GSM549120patient 078, normal, homogenized [OPG study]5.2233845
GSM549131patient 030, cancer, homogenized [OPG study]5.223946
GSM549118patient 074, normal, homogenized [OPG study]5.4826950
GSM549129patient 027, cancer, homogenized [OPG study]5.0174340
GSM549123patient 088, normal, homogenized [OPG study]5.9140257
GSM549124patient 006, cancer, homogenized [OPG study]5.1221742
GSM549126patient 015, cancer, homogenized [OPG study]5.1198843
GSM549128patient 025, cancer, homogenized [OPG study]5.1116143
GSM549103patient 117, normal, homogenized [OPG study]5.8891656
GSM549117patient 073, normal, homogenized [OPG study]5.6613353
GSM549138patient 041, cancer, homogenized [OPG study]5.0411841
GSM549141patient 045, cancer, homogenized [OPG study]4.9991141
GSM549130patient 028, cancer, homogenized [OPG study]5.2080544
GSM549101patient 111, normal, homogenized [OPG study]5.734153
GSM549105patient 128, normal, homogenized [OPG study]5.489249
GSM549106patient 134, normal, homogenized [OPG study]5.1358144
GSM549112patient 048, normal, homogenized [OPG study]5.6078752
GSM549125patient 011, cancer, homogenized [OPG study]5.2528645
GSM549127patient 024, cancer, homogenized [OPG study]5.0933142
GSM549135patient 035, cancer, homogenized [OPG study]4.9768141